Yang et al. demonstrated that upregulation of RACGAP1 is positively correlated with the stage, the grade of the tumor and the biochemical recurrence, suggesting a poor outcome for patients with PCa [44]. This evidence concerns the gene RACGAP1 and posterior cortical atrophy.